The RR (95% CIs) for antibacterial agents used to eradicate Hp was 1.11 (0.98–1.25), the risk was reduced to 0.69 (0.50–0.97) after excluding 262 patients with peptic ulcer disease (Supplementary Figures 2, 3). This evidence concerns the gene HP and peptic ulcer disease.